BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26752710)

  • 1. Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity.
    Moccia M; Adamo MF; Saviano M
    Artif DNA PNA XNA; 2014 Dec; 5(3):e1107176. PubMed ID: 26752710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide nucleic acids with a structurally biased backbone: effects of conformational constraints and stereochemistry.
    Corradini R; Sforza S; Tedeschi T; Totsingan F; Marchelli R
    Curr Top Med Chem; 2007; 7(7):681-94. PubMed ID: 17430209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide nucleic acids with a structurally biased backbone. Updated review and emerging challenges.
    Corradini R; Sforza S; Tedeschi T; Totsingan F; Manicardi A; Marchelli R
    Curr Top Med Chem; 2011; 11(12):1535-54. PubMed ID: 21510833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector.
    Finotti A; Gasparello J; Casnati A; Corradini R; Gambari R; Sansone F
    Methods Mol Biol; 2021; 2211():123-143. PubMed ID: 33336275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral peptide nucleic acids with a substituent in the N-(2-aminoethy)glycine backbone.
    Sugiyama T; Kittaka A
    Molecules; 2012 Dec; 18(1):287-310. PubMed ID: 23271467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent.
    Oh SY; Ju Y; Kim S; Park H
    Oligonucleotides; 2010 Oct; 20(5):225-30. PubMed ID: 20946011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of peptide nucleic acid with modifications of its backbone and application in biotechnology.
    Das A; Pradhan B
    Chem Biol Drug Des; 2021 Apr; 97(4):865-892. PubMed ID: 33314595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides.
    Oh SY; Ju Y; Park H
    Mol Cells; 2009 Oct; 28(4):341-5. PubMed ID: 19812898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolidinyl PNA with α/β-Dipeptide Backbone: From Development to Applications.
    Vilaivan T
    Acc Chem Res; 2015 Jun; 48(6):1645-56. PubMed ID: 26022340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of chirality and optical purity in nucleic acid recognition by PNA and PNA analogs.
    Sforza S; Galaverna G; Dossena A; Corradini R; Marchelli R
    Chirality; 2002 Jul; 14(7):591-8. PubMed ID: 12112334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chirality in gamma-PNA: PNA interaction, another piece in the picture.
    Manicardi A; Corradini R
    Artif DNA PNA XNA; 2014 Dec; 5(3):e1131801. PubMed ID: 26744081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide nucleic acid conjugates: synthesis, properties and applications.
    Zhilina ZV; Ziemba AJ; Ebbinghaus SW
    Curr Top Med Chem; 2005; 5(12):1119-31. PubMed ID: 16248787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pendant chiral C(γ)-(alkylideneamino/guanidino) cationic side-chains of PNA backbone on hybridization with complementary DNA/RNA and cell permeability.
    Jain DR; Anandi V L; Lahiri M; Ganesh KN
    J Org Chem; 2014 Oct; 79(20):9567-77. PubMed ID: 25221945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatility of peptide nucleic acids (PNAs): role in chemical biology, drug discovery, and origins of life.
    Sharma C; Awasthi SK
    Chem Biol Drug Des; 2017 Jan; 89(1):16-37. PubMed ID: 27490868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PNA-DNA duplexes, triplexes, and quadruplexes are stabilized with trans-cyclopentane units.
    Englund EA; Xu Q; Witschi MA; Appella DH
    J Am Chem Soc; 2006 Dec; 128(51):16456-7. PubMed ID: 17177367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side chain modified peptide nucleic acids (PNA) for knock-down of six3 in medaka embryos.
    Dorn S; Aghaallaei N; Jung G; Bajoghli B; Werner B; Bock H; Lindhorst T; Czerny T
    BMC Biotechnol; 2012 Aug; 12():50. PubMed ID: 22901024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular uptakes, biostabilities and anti-miR-210 activities of chiral arginine-PNAs in leukaemic K562 cells.
    Manicardi A; Fabbri E; Tedeschi T; Sforza S; Bianchi N; Brognara E; Gambari R; Marchelli R; Corradini R
    Chembiochem; 2012 Jun; 13(9):1327-37. PubMed ID: 22639449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorous Peptide Nucleic Acids: PNA Analogues with Fluorine in Backbone (γ-CF2-apg-PNA) Enhance Cellular Uptake.
    Ellipilli S; Ganesh KN
    J Org Chem; 2015 Sep; 80(18):9185-91. PubMed ID: 26322827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphono peptide nucleic acids with a constrained hydroxyproline-based backbone.
    Efimov VA; Klykov VN; Chakhmakhcheva OG
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):593-9. PubMed ID: 14565235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peptide nucleic acids (PNAs): introduction to a new class of probes for chromosomal investigation.
    Pellestor F; Paulasova P
    Chromosoma; 2004 Jun; 112(8):375-80. PubMed ID: 15156326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.